Pd(II) and Pt(II) terpyridyl complexes: topoisomerase I inhibition and cytotoxicity
Authors:
Open Access
- 8 December 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Bulletin of the Chemical Society of Japan
- Vol. 97 (3)
Abstract
Pd(II) and Pt(II) terpyridyl complexes, [MCl(terpy-COOH)]Cl (M = Pd(1) or Pt(2); terpy-COOH = 2,2':6',2''-terpyridine-4'-carboxylic acid) were synthesized. The Pd(II) complex was rapidly hydrolyzed because a Pd(II) ion was active in ligand substitution, while hydrolysis of the Pt(II) complex was slow because of its inactivity. Their topoisomerase inhibitory activity was examined: the Pd complex showed higher activity than the Pt complex. The complexes also bound with ct-DNA: the binding constant of 1 was about twice larger than that of 2. The model studies suggested that the Pd complex coordinated faster with the His residue, to which topoisomerase bound phosphate ester than the Pt complex. The cytotoxicity against HeLa cells was evaluated by adding BSA: the Pd complex 1 was more cytotoxic than cisplatin, while no cytotoxicity was observed for the Pt complex 2. The binding constants of 2 with BSA were confirmed to be similar to 1. It is fascinating that the Pd complex, which has been conventionally considered low anticancer activity, shows higher cytotoxicity than the Pt complex with the same structure.Keywords
Funding Information
- JSPS (JP20K05533)
This publication has 57 references indexed in Scilit:
- Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectivesEuropean Journal of Medicinal Chemistry, 2017
- The role of cell cycle progression for the apoptosis of cancer cells induced by palladium(II)-saccharinate complexes of terpyridineBioorganic & Medicinal Chemistry, 2017
- Comprehensive review on tumour active palladium compounds and structure–activity relationshipsCoordination Chemistry Reviews, 2016
- Platinum-based drugs: past, present and futureCancer Chemotherapy and Pharmacology, 2016
- Addition of niclosamide to palladium(II) saccharinate complex of terpyridine results in enhanced cytotoxic activity inducing apoptosis on cancer stem cells of breast cancerBioorganic & Medicinal Chemistry, 2015
- Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapyCoordination Chemistry Reviews, 2015
- Synthesis, cytotoxicity and DNA-binding properties of Pd(II), Cu(II) and Zn(II) complexes with 4′-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-2,2′:6′,2″-terpyridineBioorganic & Medicinal Chemistry Letters, 2013
- Synthesis, characterization and cytotoxicity of Pt(II), Pd(II), Cu(II) and Zn(II) complexes with 4’‐substituted terpyridineApplied Organometallic Chemistry, 2013
- Tridentate N‐Donor Palladium(II) Complexes as Efficient Coordinating Quadruplex DNA BindersChemistry – A European Journal, 2011
- Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivoEuropean Journal of Medicinal Chemistry, 2011